DCF — POST ACUTE MEDICAL OF HAMMOND
Enterprise Value: $0.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$0.4M
Enterprise Value
$-0.3M
PV of Cash Flows
$0.7M
PV of Terminal Value
$1.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $17.3M | $0.5M | 3.0% | $-0.3M | $-0.3M |
| Year 2 | $17.8M | $0.7M | 4.0% | $-0.2M | $-0.1M |
| Year 3 | $18.4M | $0.9M | 5.0% | $-0.0M | $-0.0M |
| Year 4 | $18.9M | $1.0M | 5.0% | $0.0M | $0.0M |
| Year 5 | $19.5M | $1.1M | 5.0% | $0.1M | $0.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $0.4M. Terminal value accounts for 175% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$16.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.02149617117005875
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5